ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome
- 14 December 2009
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 90 (2), 234-244
- https://doi.org/10.1038/labinvest.2009.127
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor CellsThe International Journal of Cell Cloning, 2009
- Oct4A is expressed by a subpopulation of prostate neuroendocrine cellsThe Prostate, 2008
- Prostate cancer stem cellsThe Journal of Pathology, 2008
- CD133 expression is an independent prognostic marker for low survival in colorectal cancerBritish Journal of Cancer, 2008
- Widespread Nonhematopoietic Tissue Distribution by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase ActivityThe International Journal of Cell Cloning, 2007
- Moving Forward in Human Mammary Stem Cell Biology and Breast Cancer Prognostication Using ALDH1Cell Stem Cell, 2007
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cellsOncogene, 2005